Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). - Worret,I.; Arp,W.; Zahradnik,H.P.; Andreas,J.O.; Binder,N. (Dermatology, 2001)